XBI
State Street SPDR S&P Biotech ETF
1W: +2.3%
1M: -4.1%
3M: -1.6%
YTD: +2.0%
1Y: +39.6%
3Y: +61.7%
5Y: -11.6%
$123.92
+4.38 (+3.66%)
After Hours: $123.42 (-0.50, -0.40%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$6.4B
Holdings144
Top 10 Wt16.4%
Beta1.47
% Profitable13%
Coverage100%
Portfolio Valuation
P/E37.5
P/B7.7
P/S6.9
EV/EBITDA17.9
P/FCF27.0
PEG1.87
Profitability & Returns
Gross Margin82.9%
Net Margin8.0%
ROE9.2%
ROA3.3%
ROIC8.5%
Div Yield0.12%
Leverage & Liquidity
Debt/Equity0.98
Debt/Assets0.36
Net Debt/EBITDA0.8x
Interest Cov4.0x
Current Ratio1.88
Quick Ratio1.63
Growth (YoY)
Revenue+39.4%
Net Income+14.0%
EPS+20.5%
FCF+15.5%
EBITDA+20.7%
Rev CAGR 3Y+58.3%
Quality Scores
Piotroski F4.2
Altman Z13.34
IS Quality54.7
IS Overall49.2
IS Value39.8
Median P/E-6.0
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 143 | 99.8% | -11.4 |
| Other | 10 | 0.2% | — |
Smart Money Overlap
3 holdings with signals
Showing 50 of 153 holdings
· Page 1 of 4
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | MODERNA INC | MRNA | 2.29% | $176.7M | 3,301,108 | -7.4 | $21.1B | Healthcare |
| 2 | ROIVANT SCIENCES LTD | ROIV | 1.75% | $134.6M | 4,735,100 | -23.6 | $19.6B | Healthcare |
| 3 | ARCELLX INC | ACLX | 1.74% | $133.8M | 1,145,208 | -28.2 | $6.7B | Healthcare |
| 4 | REVOLUTION MEDICINES INC | RVMD | 1.62% | $124.9M | 1,230,631 | -15.8 | $18.7B | Healthcare |
| 5 | VAXCYTE INC | PCVX | 1.58% | $121.6M | 2,203,658 | -9.9 | $8.0B | Healthcare |
| 6 | AMICUS THERAPEUTICS INC | FOLD | 1.55% | $119.4M | 8,123,986 | -164.5 | $4.5B | Healthcare |
| 7 | CG ONCOLOGY INC | CGON | 1.53% | $117.6M | 1,747,265 | -31.6 | $5.6B | Healthcare |
| 8 | GILEAD SCIENCES INC | GILD | 1.48% | $113.9M | 789,899 | 20.2 | $171.6B | Healthcare |
| 9 | MIRUM PHARMACEUTICALS INC | MIRM | 1.45% | $111.4M | 1,201,790 | -193.7 | $4.5B | Healthcare |
| 10 | PRAXIS PRECISION MEDICINES I | PRAX | 1.45% | $111.4M | 366,418 | -23.1 | $6.6B | Healthcare |
| 11 | PROTAGONIST THERAPEUTICS INC | PTGX | 1.42% | $109.0M | 1,048,842 | -51.0 | $6.7B | Healthcare |
| 12 | CELCUITY INC | CELC | 1.41% | $108.7M | 941,212 | -32.7 | $5.1B | Healthcare |
| 13 | AMGEN INC | AMGN | 1.41% | $108.7M | 303,873 | 24.7 | $190.8B | Healthcare |
| 14 | UNITED THERAPEUTICS CORP | UTHR | 1.38% | $106.5M | 197,730 | 18.0 | $23.7B | Healthcare |
| 15 | KRYSTAL BIOTECH INC | KRYS | 1.37% | $105.4M | 399,823 | 36.0 | $7.5B | Healthcare |
| 16 | CYTOKINETICS INC | CYTK | 1.33% | $102.3M | 1,589,147 | -9.7 | $7.7B | Healthcare |
| 17 | BIOGEN INC | BIIB | 1.31% | $101.2M | 539,842 | 21.5 | $27.8B | Healthcare |
| 18 | VERTEX PHARMACEUTICALS INC | VRTX | 1.31% | $100.9M | 215,536 | 29.2 | $115.6B | Healthcare |
| 19 | EXACT SCIENCES CORP | EXAS | 1.31% | $100.6M | 946,665 | -95.7 | $20.0B | Healthcare |
| 20 | BIOMARIN PHARMACEUTICAL INC | BMRN | 1.30% | $100.4M | 1,784,858 | 30.6 | $10.7B | Healthcare |
| 21 | REGENERON PHARMACEUTICALS | REGN | 1.29% | $99.5M | 131,960 | 17.1 | $77.9B | Healthcare |
| 22 | SCHOLAR ROCK HOLDING CORP | SRRK | 1.29% | $99.0M | 2,127,717 | -13.8 | $5.2B | Healthcare |
| 23 | HALOZYME THERAPEUTICS INC | HALO | 1.28% | $98.9M | 1,529,925 | 23.5 | $7.5B | Healthcare |
| 24 | EXELIXIS INC | EXEL | 1.28% | $98.4M | 2,333,786 | 14.8 | $11.5B | Healthcare |
| 25 | ALKERMES PLC | ALKS | 1.26% | $97.2M | 3,348,955 | 20.0 | $4.9B | Healthcare |
| 26 | TG THERAPEUTICS INC | TGTX | 1.26% | $97.2M | 3,132,384 | 10.2 | $5.1B | Healthcare |
| 27 | INCYTE CORP | INCY | 1.24% | $95.7M | 1,007,122 | 14.2 | $18.4B | Healthcare |
| 28 | BRIDGEBIO PHARMA INC | BBIO | 1.23% | $94.4M | 1,318,526 | -19.4 | $13.9B | Healthcare |
| 29 | IMMUNITYBIO INC | IBRX | 1.17% | $90.2M | 10,006,589 | -22.7 | $8.3B | Healthcare |
| 30 | ABBVIE INC | ABBV | 1.17% | $89.7M | 425,636 | 87.3 | $366.3B | Healthcare |
| 31 | IONIS PHARMACEUTICALS INC | IONS | 1.15% | $88.9M | 1,218,934 | -30.9 | $12.0B | Healthcare |
| 32 | PTC THERAPEUTICS INC | PTCT | 1.15% | $88.7M | 1,293,553 | 7.9 | $5.5B | Healthcare |
| 33 | VIKING THERAPEUTICS INC | VKTX | 1.15% | $88.6M | 2,554,175 | -10.5 | $3.8B | Healthcare |
| 34 | TWIST BIOSCIENCE CORP | TWST | 1.12% | $86.2M | 1,882,735 | -38.8 | $3.0B | Healthcare |
| 35 | NATERA INC | NTRA | 1.11% | $85.2M | 411,216 | -129.6 | $28.0B | Healthcare |
| 36 | RHYTHM PHARMACEUTICALS INC | RYTM | 1.10% | $84.5M | 914,960 | -28.8 | $5.8B | Healthcare |
| 37 | NEUROCRINE BIOSCIENCES INC | NBIX | 1.06% | $81.7M | 615,933 | 27.3 | $13.2B | Healthcare |
| 38 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 1.05% | $81.0M | 1,391,846 | 42.1 | $8.5B | Healthcare |
| 39 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1.05% | $80.5M | 173,486 | -35.9 | $10.6B | Healthcare |
| 40 | CRISPR THERAPEUTICS AG | CRSP | 1.04% | $79.9M | 1,664,326 | -7.3 | $4.5B | Healthcare |
| 41 | TRAVERE THERAPEUTICS INC | TVTX | 1.03% | $79.0M | 2,788,155 | -49.5 | $2.5B | Healthcare |
| 42 | KYMERA THERAPEUTICS INC | KYMR | 1.02% | $78.6M | 966,406 | -21.4 | $6.4B | Healthcare |
| 43 | DIANTHUS THERAPEUTICS INC | DNTH | 1.01% | $78.0M | 953,876 | — | $2.9B | Healthcare |
| 44 | SUMMIT THERAPEUTICS INC | SMMT | 0.99% | $76.2M | 4,742,632 | -12.4 | $13.4B | Healthcare |
| 45 | ALNYLAM PHARMACEUTICALS INC | ALNY | 0.98% | $75.4M | 237,046 | 138.5 | $43.6B | Healthcare |
| 46 | NUVALENT INC A | NUVL | 0.98% | $75.1M | 757,130 | -17.3 | $7.2B | Healthcare |
| 47 | BEAM THERAPEUTICS INC | BEAM | 0.97% | $75.0M | 2,914,183 | -29.7 | $2.4B | Healthcare |
| 48 | INSMED INC | INSM | 0.97% | $74.3M | 504,954 | -24.8 | $32.0B | Healthcare |
| 49 | TANGO THERAPEUTICS INC | TNGX | 0.96% | $73.8M | 3,735,659 | -23.9 | $2.4B | Healthcare |
| 50 | ADMA BIOLOGICS INC | ADMA | 0.96% | $73.7M | 4,797,899 | 15.6 | $2.3B | Healthcare |